Aeglea BioTherapeutics Inc (was renamed to Spyre Therapeutics (SYRE)) (AGLE)
New Form 8-K - Spyre Therapeutics, Inc. Filed: 2025-06-17 AccNo: 0001193125-25-141756 Size: 11 MB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
There are no comments here yet...